Alterity Therapeutics Statistics Share Statistics Alterity Therapeutics has 9.06M
shares outstanding. The number of shares has increased by 2.23%
in one year.
Shares Outstanding 9.06M Shares Change (YoY) 2.23% Shares Change (QoQ) -38.76% Owned by Institutions (%) 0% Shares Floating 8.63M Failed to Deliver (FTD) Shares 635 FTD / Avg. Volume 0.82%
Short Selling Information The latest short interest is 71.2K, so 0.39% of the outstanding
shares have been sold short.
Short Interest 71.2K Short % of Shares Out 0.39% Short % of Float 0.4% Short Ratio (days to cover) 4.91
Valuation Ratios The PE ratio is -5.45 and the forward
PE ratio is -4.87.
Alterity Therapeutics's PEG ratio is
0.09.
PE Ratio -5.45 Forward PE -4.87 PS Ratio 12.18 Forward PS 7.2 PB Ratio 1.56 P/FCF Ratio -5.79 PEG Ratio 0.09
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Alterity Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 12.98,
with a Debt / Equity ratio of 0.
Current Ratio 12.98 Quick Ratio 12.98 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $543.89K Profits Per Employee $-1.21M Employee Count 10 Asset Turnover 0.12 Inventory Turnover n/a
Taxes Income Tax 68.06K Effective Tax Rate -0.56%
Stock Price Statistics The stock price has increased by 200.71% in the
last 52 weeks. The beta is 0.32, so Alterity Therapeutics's
price volatility has been higher than the market average.
Beta 0.32 52-Week Price Change 200.71% 50-Day Moving Average 4.9 200-Day Moving Average 4.11 Relative Strength Index (RSI) 42.95 Average Volume (20 Days) 77,557
Income Statement In the last 12 months, Alterity Therapeutics had revenue of 5.44M
and earned -12.15M
in profits. Earnings per share was -1.14.
Revenue 5.44M Gross Profit 5.31M Operating Income -14.57M Net Income -12.15M EBITDA -14.63M EBIT -14.66M Earnings Per Share (EPS) -1.14
Full Income Statement Balance Sheet The company has 33.16M in cash and 155.46K in
debt, giving a net cash position of 33M.
Cash & Cash Equivalents 33.16M Total Debt 155.46K Net Cash 33M Retained Earnings -225.89M Total Assets 10.55M Working Capital 7.71M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.45M
and capital expenditures 0, giving a free cash flow of -11.45M.
Operating Cash Flow -11.45M Capital Expenditures n/a Free Cash Flow -11.45M FCF Per Share -1.07
Full Cash Flow Statement Margins Gross margin is 97.66%, with operating and profit margins of -267.96% and -223.35%.
Gross Margin 97.66% Operating Margin -267.96% Pretax Margin -222.1% Profit Margin -223.35% EBITDA Margin -269.05% EBIT Margin -267.96% FCF Margin -210.54%
Dividends & Yields ATHE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ATHE is $12,
which is 185% higher than the current price. The consensus rating is "Strong Buy".
Price Target $12 Price Target Difference 185% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 9, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jan 9, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -31.66 Piotroski F-Score 2
